Cargando…

Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk

INTRODUCTION: Community-based pharmacists are positioned uniquely to assist in the early detection of underlying cardiovascular disease (CVD) which affects approximately 50% of adults in the United States. Organizations utilize community-based pharmacists to conduct annual biometric health screening...

Descripción completa

Detalles Bibliográficos
Autores principales:	Newell, Bradley J., Kells, Ashley M., Robertson, Amy D., Braun, Tasha M., Ward, Kimberly S., Rohling, Brent J., Melton, Brittany L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	University of Kansas Medical Center 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136613/ https://www.ncbi.nlm.nih.gov/pubmed/37124101 http://dx.doi.org/10.17161/kjm.vol16.18514

Ejemplares similares

Highlights in ASCVD Primary Prevention for 2021
por: Polonsky, Tamar S., et al.
Publicado: (2022)

Biometrics: Accessibility challenge or opportunity?
por: Blanco-Gonzalo, Ramon, et al.
Publicado: (2018)

Gauging ASCVD Risk, Does Race Matter?
por: Zuo, Ming-Liang, et al.
Publicado: (2022)

Health Literacy is Essential to ASCVD Prevention in Youth
por: Mann, Harnoor K., et al.
Publicado: (2023)

Association of hyperuricemia combined with sarcopenia on ASCVD risk
por: Nie, Guqiao, et al.
Publicado: (2023)

A Review of Pharmacist-led Interventions on Diabetes Outcomes: An Observational Analysis to Explore Diabetes Care Opportunities for Pharmacists
por: Iqbal, Muhammad Z., et al.
Publicado: (2019)

Implementation of Pharmacist-led Telepsychiatry Services: Challenges and Opportunities in the Midst of COVID-19
por: Arain, Savera, et al.
Publicado: (2022)

Correction: Biometrics: Accessibility challenge or opportunity?
por: Blanco-Gonzalo, Ramon, et al.
Publicado: (2018)

The Potential Role of Biomarkers Associated with ASCVD Risk: Risk-Enhancing Biomarkers
por: Choi, Seonghoon
Publicado: (2019)

Expanding statin use for prevention of ASCVD in Indians: Reasoned and simplified proposals
por: Enas, Enas A., et al.
Publicado: (2020)

IMPACT OF THE COVID-19 PANDEMIC ON THE MANAGEMENT OF RISK FACTORS IN PATIENTS WITH ASCVD
por: Karalis, Dean, et al.
Publicado: (2023)

Biometric security and privacy: opportunities & challenges in the big data era
por: Jiang, Richard, et al.
Publicado: (2017)

Evaluation of the impact of enhanced virtual forms and gamification on intervention identification in a pharmacist-led ambulatory care clinic
por: Gamston, Courtney E., et al.
Publicado: (2021)

Clinical Impact of the Capacity-Motivation-Opportunity Pharmacist-Led Intervention in People Living with HIV in Spain, 2019–2020
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2022)

Pharmacist-Led Audits for Older Adults With Cancer Yield Significant Interventions
por: Erdeljac, Hilary, et al.
Publicado: (2020)

COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
por: Myers, Kelly D., et al.
Publicado: (2021)

Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia
por: Zhang, Lei, et al.
Publicado: (2019)

Combination of Endoglin and ASCVD Risk Assessment Improves Carotid Subclinical Atherosclerosis Recognition
por: Li, Qiaowei, et al.
Publicado: (2020)

RELATION OF 10-YEAR ASCVD RISK SCORE WITH SEVERE COVID-19 OUTCOMES
por: Arif, Yousif, et al.
Publicado: (2022)

Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk
por: Rikhi, Rishi, et al.
Publicado: (2022)

Analisi di costo-utilità di evolocumab in pazienti con ASCVD in Italia
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Comparison of Framingham Cardiovascular Risk Criteria and ASCVD Score in Iranian Obese Patients
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2023)

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)

A tool to help patients visualize ASCVD risk and the potential impact of risk-lowering interventions
por: Mendez, Keegan, et al.
Publicado: (2022)

Implementation of Outpatient Pharmacist-led Hypertension Management for Under-Resourced Patients: A Pilot Study
por: Stewart, Brittany, et al.
Publicado: (2021)

Pharmacist-Led Diabetes Control Intervention and Health Outcomes in Hispanic Patients With Diabetes
por: Narain, Kimberly Danae Cauley, et al.
Publicado: (2023)

Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States
por: Armstrong, Shannon O, et al.
Publicado: (2019)

Parâmetros Ecocardiográficos Simples podem Substituir o Cálculo do Modelo Probabilístico ASCVD?
por: Silva, Tonnison de Oliveira, et al.
Publicado: (2022)

External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort
por: Rodríguez-Ariza, Carlos Daniel, et al.
Publicado: (2023)

L-Arginine, Nitric Oxide, and Endothelial Dysfunction Underlying Atherosclerotic Cardiovascular Disease (ASCVD)
por: Shimabukuro, Michio
Publicado: (2023)

MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker
por: Shimabukuro, Michio
Publicado: (2023)

Pharmacist-led telemental health transitions of care clinic improves antidepressant medication continuity posthospitalization
por: Barrett, Monica, et al.
Publicado: (2020)

1274. Implementation of Pharmacist-led Medication Reconciliation in Older PLHIV
por: Karris, Maile Y, et al.
Publicado: (2022)

Impact of pharmacist-led medication management in care transitions
por: Yang, Seungwon
Publicado: (2017)

Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions
por: Tonin, Fernanda S., et al.
Publicado: (2021)

Evaluation of a pharmacist-led drive-up anticoagulation clinic during the coronavirus 2019 pandemic
por: Sherwin, Erin, et al.
Publicado: (2023)

Review of community pharmacy services: what is being performed, and where are the opportunities for improvement?
por: Melton, Brittany L, et al.
Publicado: (2017)

A case of pharmacist-led care team interventions to maximize rural patient quality of life
por: Undeberg, Megan, et al.
Publicado: (2021)

Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors
por: Dansinger, Michael L., et al.
Publicado: (2019)

Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist care
por: Dineen-Griffin, Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5f3g4mg94m060i6uouessrfe1o